| Autor: |
Sykes DL; Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, HU16 5JQ, UK., Hart SP; Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, HU16 5JQ, UK. Electronic address: s.hart@hull.ac.uk. |
| Jazyk: |
angličtina |
| Zdroj: |
The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Apr; Vol. 12 (4), pp. 256-257. Date of Electronic Publication: 2024 Jan 15. |
| DOI: |
10.1016/S2213-2600(23)00467-8 |
| Abstrakt: |
Competing Interests: SPH reports receiving grants from Boehringer Ingelheim, consulting fees from Trevi Therapeutics, payment or honoraria from Chiesi and Boehringer Ingelheim, support for attending meetings or travel (or both) from Chiesi, Boehringer Ingelheim, and Trevi Therapeutics, and is a trustee for Action for Pulmonary Fibrosis. DLS is a NIHR Academic Clinical Fellow. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
